Euro Generics International Philippines Inc.
EGIP was established in 1996 as an importer and distributor of pharmaceutical products in the Philippines. It is a Filipino corporation with the central purpose and vision to provide quality generics at affordable prices to the people of the Philippines.
Euro Generics International Philippines is specialized in medicine that needs a prescription from a licensed physician. In the past decade, EGIP has registered more than almost a hundred products with the Food and Drug Administration (FDA), many of them are now well accepted in the Philippine market. The products are being distributed through a nationwide network that includes reputable marketing and distribution companies with principal offices in Manila and Davao. Some of the company’s major brands such as Afunginal, Burnsil, Cardipres, Cetamid, Clovix, Kenzar, K-Lyte, Normanal, Probelin, Provasc, Thromaxin, and Veztenor are available in the country’s leading drug chain, Mercury Drug. In the coming years, EGIP will continue development of quality generic drugs in selected areas of medicine where there is greater need in order to continue and further improve its service to the Filipinos.
Eurogenerics International Philippines (EGIP) is a private enterprise on the initiative of Dr. Hubertus van Dierendonck, a Dutch national, who is a permanent resident of the Philippines since 1982. Dr. Bert worked many years as physician in some remote parts of the country, where he learned much about health and medicine in the Philippines. His company EGIP is a continuation of his endeavors to provide affordable medicine to the Filipinos.
After the demise of Dr.Hubertus van Dierendonck, Mr. Alec van Dierendonck assumed the role as the CEO of the company as his successor. Being the President of the corporation and regional manager of EGI Southeast Asia for the past years, he gained adequate experience to continue the legacy of his father. His vision is not only about maintaining the existing network but also expand and make Eurogenerics as one of the leading companies in the industry.
In the past decade, EGIP has registered almost 300 products with the Food and Administration (FDA), many of them are now well accepted in the market. The products are being distributed through a nationwide network that includes reputable marketing and distribution companies.
EGIP aims to become a leading pharmaceutical company specializing in the development of high-class pharmaceutical products tailor made towards the needs of its customers and markets. To achieve this, EGIP is
innovative and creative in product selection and development
excellent in maintaining the highest professional levels
pro-active in recognizing future trends within the industry
inspirational for its people who are the core of the company
loyal to its key of success: to provide quality medicine at affordable prices.
As worthy on upholding the highest professional levels, EGIP perceives the pharmaceutical industry within the context of an increasingly changing field of social and economic interactions. In this climate, the company realizes its future depends on the right decisions towards the opportunities based on the changing needs of the society and constantly being resourceful to promote outstanding product selections.